The homozygous BBS9 deletion was independently confirmed by a clinical ciliopathy sequencing panel, which reported a homozygous loss of exons 2–4 of BBS9. Exon 1 of BBS9 was not amenable to copy number analysis by sequencing due to the high GC content of this 5′ exon. Here, BBS9 is linked to ciliopathy.